nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Daunorubicin—hematologic cancer	0.151	0.599	CrCtD
Idarubicin—Anthracyclines—Daunorubicin—hematologic cancer	0.0851	0.255	CiPCiCtD
Idarubicin—TOP2A—hematologic cancer	0.0734	1	CbGaD
Idarubicin—Epirubicin—hematologic cancer	0.0526	0.208	CrCtD
Idarubicin—Doxorubicin—hematologic cancer	0.0487	0.193	CrCtD
Idarubicin—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.0445	0.133	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.0378	0.113	CiPCiCtD
Idarubicin—Doxorubicin—Daunorubicin—hematologic cancer	0.0324	0.2	CrCrCtD
Idarubicin—Valrubicin—Daunorubicin—hematologic cancer	0.0324	0.2	CrCrCtD
Idarubicin—Epirubicin—Daunorubicin—hematologic cancer	0.0324	0.2	CrCrCtD
Idarubicin—Anthracyclines—Epirubicin—hematologic cancer	0.0296	0.0887	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Irinotecan—hematologic cancer	0.0287	0.0858	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Mitoxantrone—hematologic cancer	0.0287	0.0858	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—hematologic cancer	0.0274	0.082	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—hematologic cancer	0.0225	0.0673	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0155	0.0463	CiPCiCtD
Idarubicin—TOP2A—Daunorubicin—hematologic cancer	0.015	0.126	CbGbCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—hematologic cancer	0.0143	0.0429	CiPCiCtD
Idarubicin—TOP2A—Teniposide—hematologic cancer	0.013	0.11	CbGbCtD
Idarubicin—Doxorubicin—Epirubicin—hematologic cancer	0.0113	0.0695	CrCrCtD
Idarubicin—Daunorubicin—Epirubicin—hematologic cancer	0.0113	0.0695	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—hematologic cancer	0.0113	0.0695	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—hematologic cancer	0.0104	0.0643	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—hematologic cancer	0.0104	0.0643	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—hematologic cancer	0.0104	0.0643	CrCrCtD
Idarubicin—TOP2A—Mitoxantrone—hematologic cancer	0.00912	0.0767	CbGbCtD
Idarubicin—ABCC1—Daunorubicin—hematologic cancer	0.00831	0.07	CbGbCtD
Idarubicin—TOP2A—Epirubicin—hematologic cancer	0.00738	0.0621	CbGbCtD
Idarubicin—TOP2A—Etoposide—hematologic cancer	0.00575	0.0484	CbGbCtD
Idarubicin—ABCC1—Mitoxantrone—hematologic cancer	0.00505	0.0425	CbGbCtD
Idarubicin—ABCC1—Epirubicin—hematologic cancer	0.00409	0.0344	CbGbCtD
Idarubicin—ABCC1—Irinotecan—hematologic cancer	0.00398	0.0335	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—hematologic cancer	0.00392	0.033	CbGbCtD
Idarubicin—ABCC1—Vinblastine—hematologic cancer	0.00354	0.0298	CbGbCtD
Idarubicin—CYP2C9—Bexarotene—hematologic cancer	0.00353	0.0297	CbGbCtD
Idarubicin—ABCC1—Vincristine—hematologic cancer	0.00348	0.0293	CbGbCtD
Idarubicin—ABCC1—Etoposide—hematologic cancer	0.00319	0.0268	CbGbCtD
Idarubicin—CYP2D6—Lomustine—hematologic cancer	0.003	0.0252	CbGbCtD
Idarubicin—CYP2D6—Hydroxyurea—hematologic cancer	0.00227	0.0191	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—hematologic cancer	0.00217	0.0183	CbGbCtD
Idarubicin—CYP2C9—Bortezomib—hematologic cancer	0.00216	0.0182	CbGbCtD
Idarubicin—ABCC1—Methotrexate—hematologic cancer	0.00211	0.0177	CbGbCtD
Idarubicin—CYP2D6—Bortezomib—hematologic cancer	0.00198	0.0166	CbGbCtD
Idarubicin—CYP2C9—Thalidomide—hematologic cancer	0.00188	0.0158	CbGbCtD
Idarubicin—CYP2C9—Teniposide—hematologic cancer	0.0018	0.0151	CbGbCtD
Idarubicin—CYP2C9—Ifosfamide—hematologic cancer	0.00166	0.014	CbGbCtD
Idarubicin—CYP2C9—Imatinib—hematologic cancer	0.00158	0.0133	CbGbCtD
Idarubicin—CYP2D6—Imatinib—hematologic cancer	0.00145	0.0122	CbGbCtD
Idarubicin—CYP2C9—Nilotinib—hematologic cancer	0.00144	0.0121	CbGbCtD
Idarubicin—CYP2D6—Nilotinib—hematologic cancer	0.00132	0.0111	CbGbCtD
Idarubicin—CYP2D6—Vinorelbine—hematologic cancer	0.0013	0.011	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—hematologic cancer	0.000806	0.00679	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—hematologic cancer	0.000804	0.00677	CbGbCtD
Idarubicin—CYP2C9—Dexamethasone—hematologic cancer	0.000651	0.00548	CbGbCtD
Idarubicin—CYP2D6—Dexamethasone—hematologic cancer	0.000596	0.00501	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—hematologic cancer	0.000494	0.00416	CbGbCtD
Idarubicin—Daunorubicin—TOP2B—hematologic cancer	0.000344	0.326	CrCbGaD
Idarubicin—Valrubicin—TOP2A—hematologic cancer	0.000219	0.208	CrCbGaD
Idarubicin—Epirubicin—TOP2A—hematologic cancer	9.53e-05	0.0905	CrCbGaD
Idarubicin—Doxorubicin—NQO1—hematologic cancer	7.82e-05	0.0743	CrCbGaD
Idarubicin—Doxorubicin—ABCC3—hematologic cancer	7.7e-05	0.0731	CrCbGaD
Idarubicin—TOP2A—Nilotinib—Imatinib—hematologic cancer	7.11e-05	0.0879	CbGdCrCtD
Idarubicin—Daunorubicin—TOP2A—hematologic cancer	6.74e-05	0.064	CrCbGaD
Idarubicin—Doxorubicin—TOP2A—hematologic cancer	5.47e-05	0.052	CrCbGaD
Idarubicin—Daunorubicin—ABCG2—hematologic cancer	4.61e-05	0.0437	CrCbGaD
Idarubicin—TOP2A—Topotecan—Irinotecan—hematologic cancer	3.94e-05	0.0488	CbGdCrCtD
Idarubicin—TOP2A—Etoposide—Teniposide—hematologic cancer	3.92e-05	0.0484	CbGdCrCtD
Idarubicin—Doxorubicin—ABCG2—hematologic cancer	3.74e-05	0.0355	CrCbGaD
Idarubicin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	3.53e-05	0.0436	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Teniposide—hematologic cancer	2.99e-05	0.0369	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vinblastine—hematologic cancer	2.82e-05	0.0348	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vincristine—hematologic cancer	2.82e-05	0.0348	CbGdCrCtD
Idarubicin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	2.72e-05	0.0336	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	2.66e-05	0.0329	CbGdCrCtD
Idarubicin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	2.66e-05	0.0329	CbGdCrCtD
Idarubicin—TOP2A—Menadione—Thalidomide—hematologic cancer	2.27e-05	0.028	CbGdCrCtD
Idarubicin—TOP2A—Cladribine—Pentostatin—hematologic cancer	2.06e-05	0.0254	CbGdCrCtD
Idarubicin—Daunorubicin—ABCB1—hematologic cancer	1.92e-05	0.0182	CrCbGaD
Idarubicin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	1.9e-05	0.0235	CbGdCrCtD
Idarubicin—TOP2A—Cladribine—Clofarabine—hematologic cancer	1.83e-05	0.0227	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	1.78e-05	0.022	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	1.78e-05	0.022	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—hematologic cancer	1.78e-05	0.022	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—hematologic cancer	1.78e-05	0.022	CbGdCrCtD
Idarubicin—TOP2A—Cladribine—Nelarabine—hematologic cancer	1.72e-05	0.0213	CbGdCrCtD
Idarubicin—TOP2A—Floxuridine—Cladribine—hematologic cancer	1.64e-05	0.0202	CbGdCrCtD
Idarubicin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	1.59e-05	0.0197	CbGdCrCtD
Idarubicin—Doxorubicin—ABCB1—hematologic cancer	1.56e-05	0.0148	CrCbGaD
Idarubicin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	1.53e-05	0.0189	CbGdCrCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—hematologic cancer	1.52e-05	0.0188	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	1.44e-05	0.0178	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	1.36e-05	0.0168	CbGdCrCtD
Idarubicin—TOP2A—Cladribine—Fludarabine—hematologic cancer	1.35e-05	0.0166	CbGdCrCtD
Idarubicin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	1.24e-05	0.0154	CbGdCrCtD
Idarubicin—TOP2A—Vinblastine—Vincristine—hematologic cancer	1.22e-05	0.0151	CbGdCrCtD
Idarubicin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.18e-05	0.0145	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.16e-05	0.0143	CbGdCrCtD
Idarubicin—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.15e-05	0.0142	CbGdCrCtD
Idarubicin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.09e-05	0.0135	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.06e-05	0.0131	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.03e-05	0.0128	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1e-05	0.0124	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	9.72e-06	0.012	CbGdCrCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	9.27e-06	0.0115	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	9.27e-06	0.0115	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	8.58e-06	0.0106	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	8.58e-06	0.0106	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	7.59e-06	0.00938	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	7.17e-06	0.00886	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	7.17e-06	0.00886	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Cladribine—hematologic cancer	6.99e-06	0.00863	CbGdCrCtD
Idarubicin—Infection—Triamcinolone—hematologic cancer	5.8e-06	0.000116	CcSEcCtD
Idarubicin—Shock—Triamcinolone—hematologic cancer	5.75e-06	0.000115	CcSEcCtD
Idarubicin—Alopecia—Prednisone—hematologic cancer	5.74e-06	0.000115	CcSEcCtD
Idarubicin—Nausea—Bortezomib—hematologic cancer	5.71e-06	0.000114	CcSEcCtD
Idarubicin—Hypersensitivity—Irinotecan—hematologic cancer	5.7e-06	0.000114	CcSEcCtD
Idarubicin—Hypersensitivity—Mitoxantrone—hematologic cancer	5.7e-06	0.000114	CcSEcCtD
Idarubicin—Vomiting—Thiotepa—hematologic cancer	5.7e-06	0.000114	CcSEcCtD
Idarubicin—Diarrhoea—Carmustine—hematologic cancer	5.7e-06	0.000114	CcSEcCtD
Idarubicin—Nausea—Bleomycin—hematologic cancer	5.67e-06	0.000113	CcSEcCtD
Idarubicin—Malnutrition—Prednisone—hematologic cancer	5.66e-06	0.000113	CcSEcCtD
Idarubicin—Rash—Thiotepa—hematologic cancer	5.65e-06	0.000113	CcSEcCtD
Idarubicin—Dermatitis—Thiotepa—hematologic cancer	5.65e-06	0.000113	CcSEcCtD
Idarubicin—Diarrhoea—Alitretinoin—hematologic cancer	5.65e-06	0.000113	CcSEcCtD
Idarubicin—Convulsion—Betamethasone—hematologic cancer	5.63e-06	0.000112	CcSEcCtD
Idarubicin—Convulsion—Dexamethasone—hematologic cancer	5.63e-06	0.000112	CcSEcCtD
Idarubicin—Headache—Thiotepa—hematologic cancer	5.62e-06	0.000112	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—hematologic cancer	5.6e-06	0.000112	CcSEcCtD
Idarubicin—Diarrhoea—Ifosfamide—hematologic cancer	5.58e-06	0.000111	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—hematologic cancer	5.58e-06	0.000111	CcSEcCtD
Idarubicin—Nausea—Vinorelbine—hematologic cancer	5.58e-06	0.000111	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—hematologic cancer	5.56e-06	0.000111	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—hematologic cancer	5.52e-06	0.00011	CcSEcCtD
Idarubicin—Vomiting—Thalidomide—hematologic cancer	5.51e-06	0.00011	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—hematologic cancer	5.49e-06	0.00011	CcSEcCtD
Idarubicin—Rash—Thalidomide—hematologic cancer	5.47e-06	0.000109	CcSEcCtD
Idarubicin—Dermatitis—Thalidomide—hematologic cancer	5.46e-06	0.000109	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—hematologic cancer	5.46e-06	0.000109	CcSEcCtD
Idarubicin—Diarrhoea—Vincristine—hematologic cancer	5.44e-06	0.000109	CcSEcCtD
Idarubicin—Headache—Thalidomide—hematologic cancer	5.43e-06	0.000108	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—hematologic cancer	5.43e-06	0.000108	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—hematologic cancer	5.36e-06	0.000107	CcSEcCtD
Idarubicin—Nausea—Thiotepa—hematologic cancer	5.33e-06	0.000106	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—hematologic cancer	5.32e-06	0.000106	CcSEcCtD
Idarubicin—Anaphylactic shock—Dexamethasone—hematologic cancer	5.3e-06	0.000106	CcSEcCtD
Idarubicin—Anaphylactic shock—Betamethasone—hematologic cancer	5.3e-06	0.000106	CcSEcCtD
Idarubicin—Diarrhoea—Mitoxantrone—hematologic cancer	5.3e-06	0.000106	CcSEcCtD
Idarubicin—Diarrhoea—Irinotecan—hematologic cancer	5.3e-06	0.000106	CcSEcCtD
Idarubicin—Vomiting—Carmustine—hematologic cancer	5.3e-06	0.000106	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—hematologic cancer	5.27e-06	0.000105	CcSEcCtD
Idarubicin—Infection—Dexamethasone—hematologic cancer	5.27e-06	0.000105	CcSEcCtD
Idarubicin—Infection—Betamethasone—hematologic cancer	5.27e-06	0.000105	CcSEcCtD
Idarubicin—Rash—Carmustine—hematologic cancer	5.25e-06	0.000105	CcSEcCtD
Idarubicin—Dermatitis—Carmustine—hematologic cancer	5.25e-06	0.000105	CcSEcCtD
Idarubicin—Vomiting—Alitretinoin—hematologic cancer	5.25e-06	0.000105	CcSEcCtD
Idarubicin—Anaemia—Prednisone—hematologic cancer	5.23e-06	0.000104	CcSEcCtD
Idarubicin—Headache—Carmustine—hematologic cancer	5.22e-06	0.000104	CcSEcCtD
Idarubicin—Shock—Dexamethasone—hematologic cancer	5.21e-06	0.000104	CcSEcCtD
Idarubicin—Shock—Betamethasone—hematologic cancer	5.21e-06	0.000104	CcSEcCtD
Idarubicin—Rash—Alitretinoin—hematologic cancer	5.2e-06	0.000104	CcSEcCtD
Idarubicin—Dermatitis—Alitretinoin—hematologic cancer	5.2e-06	0.000104	CcSEcCtD
Idarubicin—Thrombocytopenia—Betamethasone—hematologic cancer	5.19e-06	0.000104	CcSEcCtD
Idarubicin—Thrombocytopenia—Dexamethasone—hematologic cancer	5.19e-06	0.000104	CcSEcCtD
Idarubicin—Vomiting—Ifosfamide—hematologic cancer	5.18e-06	0.000103	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—hematologic cancer	5.18e-06	0.000103	CcSEcCtD
Idarubicin—Headache—Alitretinoin—hematologic cancer	5.17e-06	0.000103	CcSEcCtD
Idarubicin—Diarrhoea—Gemcitabine—hematologic cancer	5.16e-06	0.000103	CcSEcCtD
Idarubicin—Nausea—Thalidomide—hematologic cancer	5.15e-06	0.000103	CcSEcCtD
Idarubicin—Rash—Ifosfamide—hematologic cancer	5.14e-06	0.000103	CcSEcCtD
Idarubicin—Dermatitis—Ifosfamide—hematologic cancer	5.14e-06	0.000102	CcSEcCtD
Idarubicin—Urticaria—Etoposide—hematologic cancer	5.12e-06	0.000102	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—hematologic cancer	5.11e-06	0.000102	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—hematologic cancer	5.11e-06	0.000102	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—hematologic cancer	5.09e-06	0.000102	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—hematologic cancer	5.09e-06	0.000102	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—hematologic cancer	5.08e-06	0.000101	CcSEcCtD
Idarubicin—Vomiting—Vincristine—hematologic cancer	5.05e-06	0.000101	CcSEcCtD
Idarubicin—Anorexia—Dexamethasone—hematologic cancer	5.05e-06	0.000101	CcSEcCtD
Idarubicin—Anorexia—Betamethasone—hematologic cancer	5.05e-06	0.000101	CcSEcCtD
Idarubicin—Urticaria—Prednisolone—hematologic cancer	5.05e-06	0.000101	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—hematologic cancer	5.02e-06	0.0001	CcSEcCtD
Idarubicin—Rash—Vincristine—hematologic cancer	5.01e-06	0.0001	CcSEcCtD
Idarubicin—Dermatitis—Vincristine—hematologic cancer	5.01e-06	9.99e-05	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—hematologic cancer	4.98e-06	9.94e-05	CcSEcCtD
Idarubicin—Headache—Vincristine—hematologic cancer	4.98e-06	9.94e-05	CcSEcCtD
Idarubicin—Nausea—Carmustine—hematologic cancer	4.95e-06	9.87e-05	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—hematologic cancer	4.93e-06	9.83e-05	CcSEcCtD
Idarubicin—Vomiting—Mitoxantrone—hematologic cancer	4.92e-06	9.82e-05	CcSEcCtD
Idarubicin—Vomiting—Irinotecan—hematologic cancer	4.92e-06	9.82e-05	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—hematologic cancer	4.9e-06	9.78e-05	CcSEcCtD
Idarubicin—Nausea—Alitretinoin—hematologic cancer	4.9e-06	9.78e-05	CcSEcCtD
Idarubicin—Convulsion—Prednisone—hematologic cancer	4.9e-06	9.78e-05	CcSEcCtD
Idarubicin—Rash—Irinotecan—hematologic cancer	4.88e-06	9.74e-05	CcSEcCtD
Idarubicin—Rash—Mitoxantrone—hematologic cancer	4.88e-06	9.74e-05	CcSEcCtD
Idarubicin—Dermatitis—Mitoxantrone—hematologic cancer	4.88e-06	9.73e-05	CcSEcCtD
Idarubicin—Dermatitis—Irinotecan—hematologic cancer	4.88e-06	9.73e-05	CcSEcCtD
Idarubicin—Chills—Methotrexate—hematologic cancer	4.87e-06	9.72e-05	CcSEcCtD
Idarubicin—Headache—Irinotecan—hematologic cancer	4.85e-06	9.68e-05	CcSEcCtD
Idarubicin—Headache—Mitoxantrone—hematologic cancer	4.85e-06	9.68e-05	CcSEcCtD
Idarubicin—Nausea—Ifosfamide—hematologic cancer	4.84e-06	9.66e-05	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—hematologic cancer	4.81e-06	9.6e-05	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—hematologic cancer	4.8e-06	9.57e-05	CcSEcCtD
Idarubicin—Vomiting—Gemcitabine—hematologic cancer	4.8e-06	9.57e-05	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.78e-06	9.54e-05	CcSEcCtD
Idarubicin—Rash—Gemcitabine—hematologic cancer	4.76e-06	9.49e-05	CcSEcCtD
Idarubicin—Dermatitis—Gemcitabine—hematologic cancer	4.75e-06	9.48e-05	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—hematologic cancer	4.74e-06	9.47e-05	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—hematologic cancer	4.73e-06	9.43e-05	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—hematologic cancer	4.73e-06	9.43e-05	CcSEcCtD
Idarubicin—Headache—Gemcitabine—hematologic cancer	4.72e-06	9.43e-05	CcSEcCtD
Idarubicin—Nausea—Vincristine—hematologic cancer	4.72e-06	9.42e-05	CcSEcCtD
Idarubicin—Flushing—Epirubicin—hematologic cancer	4.72e-06	9.41e-05	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—hematologic cancer	4.7e-06	9.38e-05	CcSEcCtD
Idarubicin—Hypersensitivity—Prednisolone—hematologic cancer	4.68e-06	9.34e-05	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—hematologic cancer	4.64e-06	9.26e-05	CcSEcCtD
Idarubicin—Urticaria—Triamcinolone—hematologic cancer	4.64e-06	9.26e-05	CcSEcCtD
Idarubicin—Body temperature increased—Triamcinolone—hematologic cancer	4.62e-06	9.21e-05	CcSEcCtD
Idarubicin—Anaphylactic shock—Prednisone—hematologic cancer	4.62e-06	9.21e-05	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—hematologic cancer	4.61e-06	9.2e-05	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—hematologic cancer	4.61e-06	9.19e-05	CcSEcCtD
Idarubicin—Decreased appetite—Betamethasone—hematologic cancer	4.61e-06	9.19e-05	CcSEcCtD
Idarubicin—Decreased appetite—Dexamethasone—hematologic cancer	4.61e-06	9.19e-05	CcSEcCtD
Idarubicin—Nausea—Irinotecan—hematologic cancer	4.6e-06	9.18e-05	CcSEcCtD
Idarubicin—Nausea—Mitoxantrone—hematologic cancer	4.6e-06	9.18e-05	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—hematologic cancer	4.59e-06	9.16e-05	CcSEcCtD
Idarubicin—Infection—Prednisone—hematologic cancer	4.59e-06	9.15e-05	CcSEcCtD
Idarubicin—Chills—Epirubicin—hematologic cancer	4.56e-06	9.1e-05	CcSEcCtD
Idarubicin—Shock—Prednisone—hematologic cancer	4.54e-06	9.06e-05	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—hematologic cancer	4.54e-06	9.06e-05	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—hematologic cancer	4.49e-06	8.96e-05	CcSEcCtD
Idarubicin—Skin disorder—Prednisone—hematologic cancer	4.48e-06	8.94e-05	CcSEcCtD
Idarubicin—Nausea—Gemcitabine—hematologic cancer	4.48e-06	8.94e-05	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—hematologic cancer	4.47e-06	8.92e-05	CcSEcCtD
Idarubicin—Rash—Cisplatin—hematologic cancer	4.43e-06	8.84e-05	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—hematologic cancer	4.43e-06	8.83e-05	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—hematologic cancer	4.42e-06	8.82e-05	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—hematologic cancer	4.41e-06	8.79e-05	CcSEcCtD
Idarubicin—Anorexia—Prednisone—hematologic cancer	4.4e-06	8.78e-05	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—hematologic cancer	4.37e-06	8.72e-05	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—hematologic cancer	4.36e-06	8.71e-05	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.33e-06	8.65e-05	CcSEcCtD
Idarubicin—Gastrointestinal pain—Betamethasone—hematologic cancer	4.33e-06	8.65e-05	CcSEcCtD
Idarubicin—Hypersensitivity—Triamcinolone—hematologic cancer	4.3e-06	8.59e-05	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	4.28e-06	0.00529	CbGdCrCtD
Idarubicin—Angiopathy—Doxorubicin—hematologic cancer	4.27e-06	8.51e-05	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—hematologic cancer	4.25e-06	8.47e-05	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—hematologic cancer	4.23e-06	8.44e-05	CcSEcCtD
Idarubicin—Chills—Doxorubicin—hematologic cancer	4.22e-06	8.42e-05	CcSEcCtD
Idarubicin—Urticaria—Dexamethasone—hematologic cancer	4.21e-06	8.4e-05	CcSEcCtD
Idarubicin—Urticaria—Betamethasone—hematologic cancer	4.21e-06	8.4e-05	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—hematologic cancer	4.2e-06	8.38e-05	CcSEcCtD
Idarubicin—Abdominal pain—Betamethasone—hematologic cancer	4.19e-06	8.36e-05	CcSEcCtD
Idarubicin—Abdominal pain—Dexamethasone—hematologic cancer	4.19e-06	8.36e-05	CcSEcCtD
Idarubicin—Body temperature increased—Dexamethasone—hematologic cancer	4.19e-06	8.36e-05	CcSEcCtD
Idarubicin—Body temperature increased—Betamethasone—hematologic cancer	4.19e-06	8.36e-05	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	4.18e-06	0.00516	CbGdCrCtD
Idarubicin—Nausea—Cisplatin—hematologic cancer	4.18e-06	8.33e-05	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—hematologic cancer	4.15e-06	8.29e-05	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—hematologic cancer	4.1e-06	8.17e-05	CcSEcCtD
Idarubicin—Vomiting—Etoposide—hematologic cancer	4.09e-06	8.17e-05	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—hematologic cancer	4.09e-06	8.17e-05	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—hematologic cancer	4.09e-06	8.16e-05	CcSEcCtD
Idarubicin—Rash—Etoposide—hematologic cancer	4.06e-06	8.1e-05	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—hematologic cancer	4.06e-06	8.09e-05	CcSEcCtD
Idarubicin—Headache—Etoposide—hematologic cancer	4.03e-06	8.05e-05	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—hematologic cancer	4.02e-06	8.03e-05	CcSEcCtD
Idarubicin—Decreased appetite—Prednisone—hematologic cancer	4.01e-06	8.01e-05	CcSEcCtD
Idarubicin—Rash—Prednisolone—hematologic cancer	4.01e-06	7.99e-05	CcSEcCtD
Idarubicin—Dermatitis—Prednisolone—hematologic cancer	4e-06	7.98e-05	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4e-06	7.97e-05	CcSEcCtD
Idarubicin—Headache—Prednisolone—hematologic cancer	3.98e-06	7.94e-05	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—hematologic cancer	3.96e-06	7.9e-05	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—hematologic cancer	3.86e-06	7.7e-05	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—hematologic cancer	3.83e-06	7.65e-05	CcSEcCtD
Idarubicin—Infection—Methotrexate—hematologic cancer	3.83e-06	7.65e-05	CcSEcCtD
Idarubicin—Nausea—Etoposide—hematologic cancer	3.83e-06	7.63e-05	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—hematologic cancer	3.78e-06	7.55e-05	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—hematologic cancer	3.78e-06	7.54e-05	CcSEcCtD
Idarubicin—Gastrointestinal pain—Prednisone—hematologic cancer	3.77e-06	7.53e-05	CcSEcCtD
Idarubicin—Nausea—Prednisolone—hematologic cancer	3.77e-06	7.53e-05	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—hematologic cancer	3.77e-06	7.51e-05	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—hematologic cancer	3.75e-06	7.48e-05	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.74e-06	7.46e-05	CcSEcCtD
Idarubicin—Vomiting—Triamcinolone—hematologic cancer	3.71e-06	7.41e-05	CcSEcCtD
Idarubicin—Rash—Triamcinolone—hematologic cancer	3.68e-06	7.35e-05	CcSEcCtD
Idarubicin—Dermatitis—Triamcinolone—hematologic cancer	3.68e-06	7.34e-05	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—hematologic cancer	3.68e-06	7.34e-05	CcSEcCtD
Idarubicin—Urticaria—Prednisone—hematologic cancer	3.67e-06	7.32e-05	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—hematologic cancer	3.66e-06	7.31e-05	CcSEcCtD
Idarubicin—Headache—Triamcinolone—hematologic cancer	3.66e-06	7.3e-05	CcSEcCtD
Idarubicin—Abdominal pain—Prednisone—hematologic cancer	3.65e-06	7.28e-05	CcSEcCtD
Idarubicin—Body temperature increased—Prednisone—hematologic cancer	3.65e-06	7.28e-05	CcSEcCtD
Idarubicin—Diarrhoea—Betamethasone—hematologic cancer	3.63e-06	7.24e-05	CcSEcCtD
Idarubicin—Diarrhoea—Dexamethasone—hematologic cancer	3.63e-06	7.24e-05	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—hematologic cancer	3.61e-06	7.2e-05	CcSEcCtD
Idarubicin—Infection—Epirubicin—hematologic cancer	3.59e-06	7.16e-05	CcSEcCtD
Idarubicin—Shock—Epirubicin—hematologic cancer	3.55e-06	7.09e-05	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—hematologic cancer	3.55e-06	7.07e-05	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—hematologic cancer	3.53e-06	7.05e-05	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—hematologic cancer	3.51e-06	7e-05	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—hematologic cancer	3.48e-06	6.95e-05	CcSEcCtD
Idarubicin—Nausea—Triamcinolone—hematologic cancer	3.47e-06	6.92e-05	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.46e-06	6.9e-05	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—hematologic cancer	3.44e-06	6.87e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—SPHK1—hematologic cancer	3.44e-06	0.000477	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.43e-06	0.000476	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTR—hematologic cancer	3.42e-06	0.000475	CbGpPWpGaD
Idarubicin—ABCC1—Disease—XIAP—hematologic cancer	3.42e-06	0.000475	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—hematologic cancer	3.41e-06	0.000474	CbGpPWpGaD
Idarubicin—Hypersensitivity—Prednisone—hematologic cancer	3.4e-06	6.78e-05	CcSEcCtD
Idarubicin—Vomiting—Betamethasone—hematologic cancer	3.37e-06	6.72e-05	CcSEcCtD
Idarubicin—Vomiting—Dexamethasone—hematologic cancer	3.37e-06	6.72e-05	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—hematologic cancer	3.35e-06	6.69e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—ENO2—hematologic cancer	3.35e-06	0.000466	CbGpPWpGaD
Idarubicin—Rash—Dexamethasone—hematologic cancer	3.34e-06	6.67e-05	CcSEcCtD
Idarubicin—Rash—Betamethasone—hematologic cancer	3.34e-06	6.67e-05	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—hematologic cancer	3.34e-06	6.66e-05	CcSEcCtD
Idarubicin—Dermatitis—Dexamethasone—hematologic cancer	3.34e-06	6.66e-05	CcSEcCtD
Idarubicin—Dermatitis—Betamethasone—hematologic cancer	3.34e-06	6.66e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—SMARCA4—hematologic cancer	3.33e-06	0.000463	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	3.32e-06	0.000462	CbGpPWpGaD
Idarubicin—Headache—Betamethasone—hematologic cancer	3.32e-06	6.62e-05	CcSEcCtD
Idarubicin—Headache—Dexamethasone—hematologic cancer	3.32e-06	6.62e-05	CcSEcCtD
Idarubicin—Infection—Doxorubicin—hematologic cancer	3.32e-06	6.62e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—UGT1A1—hematologic cancer	3.3e-06	0.000459	CbGpPWpGaD
Idarubicin—Shock—Doxorubicin—hematologic cancer	3.29e-06	6.56e-05	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—hematologic cancer	3.27e-06	6.52e-05	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—hematologic cancer	3.24e-06	6.47e-05	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	3.21e-06	0.000447	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC22A1—hematologic cancer	3.21e-06	0.000446	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CRABP1—hematologic cancer	3.21e-06	0.000446	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.21e-06	0.000445	CbGpPWpGaD
Idarubicin—Anorexia—Doxorubicin—hematologic cancer	3.18e-06	6.35e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—SDC1—hematologic cancer	3.18e-06	0.000442	CbGpPWpGaD
Idarubicin—Diarrhoea—Prednisone—hematologic cancer	3.16e-06	6.3e-05	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—hematologic cancer	3.15e-06	6.29e-05	CcSEcCtD
Idarubicin—Nausea—Betamethasone—hematologic cancer	3.15e-06	6.28e-05	CcSEcCtD
Idarubicin—Nausea—Dexamethasone—hematologic cancer	3.15e-06	6.28e-05	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—hematologic cancer	3.14e-06	6.26e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—ALOX5—hematologic cancer	3.13e-06	0.000435	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.12e-06	0.000434	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	3.11e-06	0.000433	CbGpPWpGaD
Idarubicin—ABCC1—Disease—LCK—hematologic cancer	3.08e-06	0.000428	CbGpPWpGaD
Idarubicin—Urticaria—Methotrexate—hematologic cancer	3.06e-06	6.11e-05	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	3.06e-06	0.000425	CbGpPWpGaD
Idarubicin—Body temperature increased—Methotrexate—hematologic cancer	3.05e-06	6.08e-05	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—hematologic cancer	3.05e-06	6.08e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—NUP98—hematologic cancer	3.03e-06	0.000421	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ASNS—hematologic cancer	3.03e-06	0.000421	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—DCK—hematologic cancer	3.03e-06	0.000421	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—B3GAT1—hematologic cancer	3.03e-06	0.000421	CbGpPWpGaD
Idarubicin—ABCC1—Disease—H3F3A—hematologic cancer	3.02e-06	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ASNS—hematologic cancer	3e-06	0.000417	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—DCK—hematologic cancer	3e-06	0.000417	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—B3GAT1—hematologic cancer	3e-06	0.000417	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—hematologic cancer	2.97e-06	0.000413	CbGpPWpGaD
Idarubicin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.95e-06	5.89e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—ADCY7—hematologic cancer	2.94e-06	0.000409	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOA3—hematologic cancer	2.94e-06	0.000409	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.94e-06	0.000408	CbGpPWpGaD
Idarubicin—Vomiting—Prednisone—hematologic cancer	2.93e-06	5.86e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—PRKCZ—hematologic cancer	2.93e-06	0.000407	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NUP214—hematologic cancer	2.92e-06	0.000406	CbGpPWpGaD
Idarubicin—Rash—Prednisone—hematologic cancer	2.91e-06	5.81e-05	CcSEcCtD
Idarubicin—Dermatitis—Prednisone—hematologic cancer	2.91e-06	5.8e-05	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—hematologic cancer	2.9e-06	5.79e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.89e-06	0.000402	CbGpPWpGaD
Idarubicin—Headache—Prednisone—hematologic cancer	2.89e-06	5.77e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—CALR—hematologic cancer	2.88e-06	0.0004	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	2.87e-06	0.000399	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HDC—hematologic cancer	2.87e-06	0.000399	CbGpPWpGaD
Idarubicin—Urticaria—Epirubicin—hematologic cancer	2.87e-06	5.72e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—MTR—hematologic cancer	2.86e-06	0.000398	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCG2—hematologic cancer	2.86e-06	0.000398	CbGpPWpGaD
Idarubicin—Abdominal pain—Epirubicin—hematologic cancer	2.85e-06	5.69e-05	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—hematologic cancer	2.85e-06	5.69e-05	CcSEcCtD
Idarubicin—CYP2C9—Metabolism—HDC—hematologic cancer	2.85e-06	0.000396	CbGpPWpGaD
Idarubicin—Hypersensitivity—Methotrexate—hematologic cancer	2.84e-06	5.67e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—PARP1—hematologic cancer	2.83e-06	0.000394	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO2—hematologic cancer	2.81e-06	0.00039	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FBXW7—hematologic cancer	2.79e-06	0.000387	CbGpPWpGaD
Idarubicin—Nausea—Prednisone—hematologic cancer	2.74e-06	5.47e-05	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.74e-06	0.000381	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—EP300—hematologic cancer	2.73e-06	0.00038	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HDAC2—hematologic cancer	2.73e-06	0.00038	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CXCR4—hematologic cancer	2.73e-06	0.00038	CbGpPWpGaD
Idarubicin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.73e-06	5.45e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—GSTT1—hematologic cancer	2.72e-06	0.000378	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD44—hematologic cancer	2.7e-06	0.000375	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.68e-06	0.000373	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	2.67e-06	0.00037	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CBL—hematologic cancer	2.66e-06	0.00037	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SDC1—hematologic cancer	2.66e-06	0.00037	CbGpPWpGaD
Idarubicin—Hypersensitivity—Epirubicin—hematologic cancer	2.66e-06	5.31e-05	CcSEcCtD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.66e-06	0.000369	CbGpPWpGaD
Idarubicin—Urticaria—Doxorubicin—hematologic cancer	2.65e-06	5.29e-05	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—hematologic cancer	2.64e-06	5.27e-05	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—hematologic cancer	2.64e-06	5.27e-05	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—hematologic cancer	2.64e-06	5.27e-05	CcSEcCtD
Idarubicin—CYP2D6—Metabolism—CDA—hematologic cancer	2.63e-06	0.000365	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CDA—hematologic cancer	2.61e-06	0.000362	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.55e-06	0.000354	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.54e-06	0.000353	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HSP90AA1—hematologic cancer	2.54e-06	0.000353	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PC—hematologic cancer	2.53e-06	0.000351	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.51e-06	0.000349	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PC—hematologic cancer	2.51e-06	0.000348	CbGpPWpGaD
Idarubicin—Diarrhoea—Epirubicin—hematologic cancer	2.47e-06	4.93e-05	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—hematologic cancer	2.46e-06	4.91e-05	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—hematologic cancer	2.45e-06	4.89e-05	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	2.45e-06	0.00034	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT1—hematologic cancer	2.45e-06	0.00034	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.44e-06	0.000339	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GBA—hematologic cancer	2.44e-06	0.000339	CbGpPWpGaD
Idarubicin—Rash—Methotrexate—hematologic cancer	2.43e-06	4.85e-05	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—hematologic cancer	2.43e-06	4.85e-05	CcSEcCtD
Idarubicin—CYP2C9—Metabolism—GBA—hematologic cancer	2.42e-06	0.000337	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.42e-06	0.000337	CbGpPWpGaD
Idarubicin—Headache—Methotrexate—hematologic cancer	2.42e-06	4.82e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.4e-06	0.000334	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.39e-06	0.000332	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—hematologic cancer	2.38e-06	0.000331	CbGpPWpGaD
Idarubicin—Vomiting—Epirubicin—hematologic cancer	2.3e-06	4.58e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—GRB2—hematologic cancer	2.29e-06	0.000318	CbGpPWpGaD
Idarubicin—Nausea—Methotrexate—hematologic cancer	2.29e-06	4.57e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—PDGFA—hematologic cancer	2.29e-06	0.000318	CbGpPWpGaD
Idarubicin—Diarrhoea—Doxorubicin—hematologic cancer	2.29e-06	4.56e-05	CcSEcCtD
Idarubicin—Rash—Epirubicin—hematologic cancer	2.28e-06	4.54e-05	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—hematologic cancer	2.27e-06	4.54e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—NQO1—hematologic cancer	2.26e-06	0.000314	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CD44—hematologic cancer	2.26e-06	0.000314	CbGpPWpGaD
Idarubicin—Headache—Epirubicin—hematologic cancer	2.26e-06	4.51e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—KITLG—hematologic cancer	2.25e-06	0.000313	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTAP—hematologic cancer	2.23e-06	0.00031	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.22e-06	0.000308	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTAP—hematologic cancer	2.22e-06	0.000308	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT5A—hematologic cancer	2.2e-06	0.000306	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—hematologic cancer	2.18e-06	0.000303	CbGpPWpGaD
Idarubicin—Nausea—Epirubicin—hematologic cancer	2.14e-06	4.28e-05	CcSEcCtD
Idarubicin—ABCC1—Metabolism—CYCS—hematologic cancer	2.14e-06	0.000297	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HSP90AA1—hematologic cancer	2.13e-06	0.000296	CbGpPWpGaD
Idarubicin—Vomiting—Doxorubicin—hematologic cancer	2.12e-06	4.24e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—CD86—hematologic cancer	2.11e-06	0.000293	CbGpPWpGaD
Idarubicin—Rash—Doxorubicin—hematologic cancer	2.11e-06	4.2e-05	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—hematologic cancer	2.1e-06	4.2e-05	CcSEcCtD
Idarubicin—Headache—Doxorubicin—hematologic cancer	2.09e-06	4.17e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—HES1—hematologic cancer	2.08e-06	0.000289	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NCOR1—hematologic cancer	2.07e-06	0.000288	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF1—hematologic cancer	2.05e-06	0.000285	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FOXO1—hematologic cancer	2.02e-06	0.00028	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFRB—hematologic cancer	2.01e-06	0.00028	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—FHL2—hematologic cancer	1.99e-06	0.000277	CbGpPWpGaD
Idarubicin—Nausea—Doxorubicin—hematologic cancer	1.98e-06	3.96e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—PDGFRA—hematologic cancer	1.98e-06	0.000276	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JAK1—hematologic cancer	1.98e-06	0.000275	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PRKCG—hematologic cancer	1.98e-06	0.000275	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—FHL2—hematologic cancer	1.97e-06	0.000274	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—hematologic cancer	1.96e-06	0.000272	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AGRN—hematologic cancer	1.95e-06	0.000271	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AGRN—hematologic cancer	1.94e-06	0.000269	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.91e-06	0.000266	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—hematologic cancer	1.89e-06	0.000262	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH2—hematologic cancer	1.85e-06	0.000257	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMMR—hematologic cancer	1.85e-06	0.000257	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMMR—hematologic cancer	1.84e-06	0.000255	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH2—hematologic cancer	1.84e-06	0.000255	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTHFR—hematologic cancer	1.83e-06	0.000254	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.83e-06	0.000254	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TERT—hematologic cancer	1.83e-06	0.000254	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HLA-A—hematologic cancer	1.83e-06	0.000254	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—hematologic cancer	1.79e-06	0.000248	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFB—hematologic cancer	1.78e-06	0.000248	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TSC2—hematologic cancer	1.74e-06	0.000242	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.74e-06	0.000242	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOR1—hematologic cancer	1.73e-06	0.000241	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—hematologic cancer	1.73e-06	0.000241	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.73e-06	0.00024	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.73e-06	0.00024	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACP5—hematologic cancer	1.69e-06	0.000235	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA9—hematologic cancer	1.69e-06	0.000235	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACP5—hematologic cancer	1.68e-06	0.000233	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA9—hematologic cancer	1.68e-06	0.000233	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGFR3—hematologic cancer	1.67e-06	0.000233	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.67e-06	0.000232	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.66e-06	0.00023	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH1—hematologic cancer	1.59e-06	0.000221	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BAD—hematologic cancer	1.59e-06	0.000221	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH1—hematologic cancer	1.58e-06	0.000219	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.57e-06	0.000219	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.57e-06	0.000219	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TXN—hematologic cancer	1.57e-06	0.000219	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—hematologic cancer	1.57e-06	0.000218	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.56e-06	0.000217	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.56e-06	0.000217	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TXN—hematologic cancer	1.56e-06	0.000217	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.54e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD80—hematologic cancer	1.54e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—hematologic cancer	1.54e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—MTHFR—hematologic cancer	1.53e-06	0.000213	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.53e-06	0.000212	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTPN11—hematologic cancer	1.51e-06	0.00021	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.48e-06	0.000206	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.47e-06	0.000204	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CREB1—hematologic cancer	1.46e-06	0.000203	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—hematologic cancer	1.45e-06	0.000201	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.44e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.44e-06	0.0002	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6R—hematologic cancer	1.43e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.43e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.43e-06	0.000198	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CREBBP—hematologic cancer	1.43e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.4e-06	0.000195	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.39e-06	0.000193	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAP2K1—hematologic cancer	1.36e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NUP98—hematologic cancer	1.36e-06	0.000189	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CD—hematologic cancer	1.35e-06	0.000188	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.35e-06	0.000188	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NUP98—hematologic cancer	1.35e-06	0.000187	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.32e-06	0.000183	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.32e-06	0.000183	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NUP214—hematologic cancer	1.31e-06	0.000182	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.31e-06	0.000182	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.31e-06	0.000182	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NUP214—hematologic cancer	1.3e-06	0.00018	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF2—hematologic cancer	1.29e-06	0.00018	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—hematologic cancer	1.29e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.29e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.28e-06	0.000178	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTR—hematologic cancer	1.28e-06	0.000178	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3R1—hematologic cancer	1.28e-06	0.000177	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTR—hematologic cancer	1.27e-06	0.000177	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.27e-06	0.000177	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO2—hematologic cancer	1.26e-06	0.000175	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO2—hematologic cancer	1.25e-06	0.000173	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JAK2—hematologic cancer	1.24e-06	0.000172	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.22e-06	0.00017	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—hematologic cancer	1.21e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.21e-06	0.000168	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CREBBP—hematologic cancer	1.19e-06	0.000166	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SDC1—hematologic cancer	1.19e-06	0.000166	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.19e-06	0.000166	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SDC1—hematologic cancer	1.18e-06	0.000164	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTOR—hematologic cancer	1.18e-06	0.000164	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CB—hematologic cancer	1.18e-06	0.000164	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD4—hematologic cancer	1.18e-06	0.000163	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CD—hematologic cancer	1.13e-06	0.000157	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.13e-06	0.000157	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALB—hematologic cancer	1.12e-06	0.000155	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.12e-06	0.000155	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1B—hematologic cancer	1.11e-06	0.000154	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3R1—hematologic cancer	1.07e-06	0.000149	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.07e-06	0.000148	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—hematologic cancer	1.02e-06	0.000142	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—hematologic cancer	1.02e-06	0.000141	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NQO1—hematologic cancer	1.01e-06	0.000141	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CD44—hematologic cancer	1.01e-06	0.000141	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CD44—hematologic cancer	1.01e-06	0.00014	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NQO1—hematologic cancer	1.01e-06	0.00014	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CB—hematologic cancer	9.87e-07	0.000137	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.85e-07	0.000137	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EP300—hematologic cancer	9.71e-07	0.000135	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYCS—hematologic cancer	9.6e-07	0.000133	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	9.54e-07	0.000133	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYCS—hematologic cancer	9.52e-07	0.000132	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	9.46e-07	0.000131	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SRC—hematologic cancer	9.44e-07	0.000131	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—hematologic cancer	9.11e-07	0.000127	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NRAS—hematologic cancer	9.08e-07	0.000126	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—hematologic cancer	8.7e-07	0.000121	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—hematologic cancer	8.53e-07	0.000118	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.51e-07	0.000118	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—hematologic cancer	8.46e-07	0.000118	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—hematologic cancer	8.46e-07	0.000118	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFB1—hematologic cancer	8.44e-07	0.000117	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—hematologic cancer	8.39e-07	0.000117	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—EP300—hematologic cancer	8.13e-07	0.000113	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.12e-07	0.000113	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—hematologic cancer	8.01e-07	0.000111	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—hematologic cancer	7.94e-07	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—hematologic cancer	7.82e-07	0.000109	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—hematologic cancer	7.78e-07	0.000108	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOR1—hematologic cancer	7.78e-07	0.000108	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOR1—hematologic cancer	7.71e-07	0.000107	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—hematologic cancer	7.71e-07	0.000107	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—hematologic cancer	7.18e-07	9.98e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTHFR—hematologic cancer	6.87e-07	9.55e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTHFR—hematologic cancer	6.81e-07	9.46e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—hematologic cancer	6.65e-07	9.23e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—hematologic cancer	6.36e-07	8.84e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—hematologic cancer	6.02e-07	8.36e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6e-07	8.34e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—hematologic cancer	5.87e-07	8.15e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.77e-07	8.02e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.72e-07	7.95e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.35e-07	7.44e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.31e-07	7.37e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.08e-07	7.05e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	5.03e-07	6.99e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALB—hematologic cancer	5.01e-07	6.96e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALB—hematologic cancer	4.97e-07	6.9e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—hematologic cancer	4.91e-07	6.83e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.79e-07	6.66e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.75e-07	6.6e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.42e-07	6.15e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.39e-07	6.09e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—hematologic cancer	3.82e-07	5.31e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—hematologic cancer	3.79e-07	5.27e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—EP300—hematologic cancer	3.65e-07	5.07e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—EP300—hematologic cancer	3.61e-07	5.02e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.7e-07	3.75e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.67e-07	3.71e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—hematologic cancer	2.2e-07	3.06e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—hematologic cancer	2.18e-07	3.03e-05	CbGpPWpGaD
